BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 25583948)

  • 1. Body mass index is associated with gene methylation in estrogen receptor-positive breast tumors.
    Hair BY; Troester MA; Edmiston SN; Parrish EA; Robinson WR; Wu MC; Olshan AF; Swift-Scanlan T; Conway K
    Cancer Epidemiol Biomarkers Prev; 2015 Mar; 24(3):580-6. PubMed ID: 25583948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methylation and hormone receptor status in breast cancer.
    Benevolenskaya EV; Islam AB; Ahsan H; Kibriya MG; Jasmine F; Wolff B; Al-Alem U; Wiley E; Kajdacsy-Balla A; Macias V; Rauscher GH
    Clin Epigenetics; 2016; 8():17. PubMed ID: 26884818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial variation in breast tumor promoter methylation in the Carolina Breast Cancer Study.
    Conway K; Edmiston SN; Tse CK; Bryant C; Kuan PF; Hair BY; Parrish EA; May R; Swift-Scanlan T
    Cancer Epidemiol Biomarkers Prev; 2015 Jun; 24(6):921-30. PubMed ID: 25809865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesity-associated methylation in breast tumors: a possible link to disparate outcomes?
    Do WL; Conneely K; Gabram-Mendola S; Krishnamurti U; D'Angelo O; Miller-Kleinhenz J; Gogineni K; Torres M; McCullough LE
    Breast Cancer Res Treat; 2020 May; 181(1):135-144. PubMed ID: 32236829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological significance and potential drug target of CDH1 in breast cancer: a meta-analysis and literature review.
    Huang R; Ding P; Yang F
    Drug Des Devel Ther; 2015; 9():5277-85. PubMed ID: 26425077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic Changes of the ESR1 Gene in Breast Tissue of Healthy Women: A Missing Link with Breast Cancer Risk Factors?
    Daraei A; Izadi P; Khorasani G; Nafissi N; Naghizadeh MM; Younosi N; Meysamie A; Mansoori Y; Bastami M; Tavakkoly-Bazzaz J
    Genet Test Mol Biomarkers; 2017 Aug; 21(8):464-470. PubMed ID: 28708432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated analysis of DNA methylation, immunohistochemistry and mRNA expression, data identifies a methylation expression index (MEI) robustly associated with survival of ER-positive breast cancer patients.
    Figueroa JD; Yang H; Garcia-Closas M; Davis S; Meltzer P; Lissowska J; Horne HN; Sherman ME; Lee M
    Breast Cancer Res Treat; 2015 Apr; 150(2):457-466. PubMed ID: 25773928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aging impacts transcriptomes but not genomes of hormone-dependent breast cancers.
    Yau C; Fedele V; Roydasgupta R; Fridlyand J; Hubbard A; Gray JW; Chew K; Dairkee SH; Moore DH; Schittulli F; Tommasi S; Paradiso A; Albertson DG; Benz CC
    Breast Cancer Res; 2007; 9(5):R59. PubMed ID: 17850661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between body mass index and the expression of hormone receptors or human epidermal growth factor receptor 2 with respect to breast cancer survival.
    Jeon YW; Kang SH; Park MH; Lim W; Cho SH; Suh YJ
    BMC Cancer; 2015 Nov; 15():865. PubMed ID: 26546331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A gene transcription signature of obesity in breast cancer.
    Creighton CJ; Sada YH; Zhang Y; Tsimelzon A; Wong H; Dave B; Landis MD; Bear HD; Rodriguez A; Chang JC
    Breast Cancer Res Treat; 2012 Apr; 132(3):993-1000. PubMed ID: 21750966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen receptor gene methylation in human breast tumors.
    Falette NS; Fuqua SA; Chamness GC; Cheah MS; Greene GL; McGuire WL
    Cancer Res; 1990 Jul; 50(13):3974-8. PubMed ID: 2354445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Body weight at age 20 years, subsequent weight change and breast cancer risk defined by estrogen and progesterone receptor status--the Japan public health center-based prospective study.
    Suzuki R; Iwasaki M; Inoue M; Sasazuki S; Sawada N; Yamaji T; Shimazu T; Tsugane S;
    Int J Cancer; 2011 Sep; 129(5):1214-24. PubMed ID: 21064092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
    Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
    Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of HSF1 in estrogen receptor positive breast cancer.
    Gökmen-Polar Y; Badve S
    Oncotarget; 2016 Dec; 7(51):84239-84245. PubMed ID: 27713164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide methylation analysis identifies genes specific to breast cancer hormone receptor status and risk of recurrence.
    Fackler MJ; Umbricht CB; Williams D; Argani P; Cruz LA; Merino VF; Teo WW; Zhang Z; Huang P; Visvananthan K; Marks J; Ethier S; Gray JW; Wolff AC; Cope LM; Sukumar S
    Cancer Res; 2011 Oct; 71(19):6195-207. PubMed ID: 21825015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adult body size and physical activity in relation to risk of breast cancer according to tumor androgen receptor status.
    Zhang X; Eliassen AH; Tamimi RM; Hazra A; Beck AH; Brown M; Collins LC; Rosner B; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2015 Jun; 24(6):962-8. PubMed ID: 25855627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between CpG methylation profiles and hormone receptor status in breast cancers.
    Feng W; Shen L; Wen S; Rosen DG; Jelinek J; Hu X; Huan S; Huang M; Liu J; Sahin AA; Hunt KK; Bast RC; Shen Y; Issa JP; Yu Y
    Breast Cancer Res; 2007; 9(4):R57. PubMed ID: 17764565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen and progesterone receptor status affect genome-wide DNA methylation profile in breast cancer.
    Li L; Lee KM; Han W; Choi JY; Lee JY; Kang GH; Park SK; Noh DY; Yoo KY; Kang D
    Hum Mol Genet; 2010 Nov; 19(21):4273-7. PubMed ID: 20724461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roadmap of DNA methylation in breast cancer identifies novel prognostic biomarkers.
    de Almeida BP; Apolónio JD; Binnie A; Castelo-Branco P
    BMC Cancer; 2019 Mar; 19(1):219. PubMed ID: 30866861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study of the CpG methylation status of ER alpha gene in estrogen receptor alpha-negative breast cancer cell lines and the role of hydralazine demethylation].
    Tang B; Jiang J
    Zhonghua Bing Li Xue Za Zhi; 2005 May; 34(5):283-7. PubMed ID: 16181550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.